<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/7369E051-ECFC-4808-A044-651879C318D1"><gtr:id>7369E051-ECFC-4808-A044-651879C318D1</gtr:id><gtr:name>MRC Cancer Cell Unit</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB2 2XZ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7369E051-ECFC-4808-A044-651879C318D1"><gtr:id>7369E051-ECFC-4808-A044-651879C318D1</gtr:id><gtr:name>MRC Cancer Cell Unit</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB2 2XZ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EFC5F760-3112-4C93-959E-0ABFF0F79190"><gtr:id>EFC5F760-3112-4C93-959E-0ABFF0F79190</gtr:id><gtr:firstName>Christian</gtr:firstName><gtr:surname>Frezza</gtr:surname><gtr:orcidId>0000-0002-3293-7397</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_1101%2F3"><gtr:id>4D28B12B-482D-4529-883F-B6B3D4900348</gtr:id><gtr:title>Investigation of the role of metabolism in tumorigenesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_1101/3</gtr:grantReference><gtr:abstractText>Cancer is currently viewed as a genetic disease whereby well-characterised gene mutations are sufficient to drive unrestrained growth and proliferation. In order to support proliferation, cancer cells utilise a specific set of nutrients, among which glucose and glutamine are the most important. It has been shown that inherent dysfunctions of glucose and glutamine metabolism in some circumstances predispose to cancer formation. However, how altered metabolism drives tumorigenesis in not fully understood.

In this project, we intend to investigate the role of genes involved in cell metabolism in cancer formation. We will start by studying the role of these genes in altering cell metabolism using cell culture models. Then, we will move into animal models to define how each candidate gene triggers tumorigenesis in vivo. 

Our goal is to find metabolic pathways required for the survival of these mutant tumours in order to determine potential anti-cancer drug targets. Furthermore, we aim to detect early signs of these metabolic changes in body fluids such as urine and blood, in order to discover novel biomarkers for the early detection of cancer.</gtr:abstractText><gtr:technicalSummary>Our work is focused at understanding the role of altered cellular metabolism in the process of cancer transformation. In particular, we study how mitochondrial dysfunction leads to a global metabolic rewiring that, in turn, promotesgenetic and epigenetic changes that predispose to tumorigenesis. To do this, we use a combination of biochemistry, metabolomics and computational biology both in vitro and in vivo. Our goal is to find metabolic pathways that are specifically exploited by cancer cells that can be targeted achieving tumour-specific chemotherapy.</gtr:technicalSummary><gtr:fund><gtr:end>2013-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-05-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>450758</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cambridge Science Festival 2013</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>04D089BA-CE13-4251-AE78-9790DAB917C7</gtr:id><gtr:impact>Around 4000 people visited the Biology zone and took part in a range of activities.

Increased awareness of cancer research.</gtr:impact><gtr:outcomeId>ebHyp8NuVUM</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival 2014</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3EB6FF76-4CFC-49F8-BF77-9554EBD30905</gtr:id><gtr:impact>Discussed research and coordinated activities

Increased awareness of research</gtr:impact><gtr:outcomeId>543e5329e292d1.26476504</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Centenary Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>926EEECA-194B-406D-B183-3F2060F8E53C</gtr:id><gtr:impact>Around 100 students and teachers heard about the variety of cancer research and tool part in some lab activities.

Increased engagement with local schools and biology teachers.</gtr:impact><gtr:outcomeId>ptoNXNMEw5Q</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cambridge Cancer Centre Pump Priming Award</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>Cambridge Cancer Centre</gtr:fundingOrg><gtr:id>5EC4D31D-A48A-48CE-822F-7CA93DEEB0A8</gtr:id><gtr:outcomeId>545d2d855a0634.31179571</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>EC780C2F-7DDF-45C2-A121-9A483D0CC081</gtr:id><gtr:title>Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2de4c0d76977e46505843f808e6c5494"><gtr:id>2de4c0d76977e46505843f808e6c5494</gtr:id><gtr:otherNames>Yizhak K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>55d2dfc735bc89.46947913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE451A30-6585-40AA-8A66-4ED37DF617BA</gtr:id><gtr:title>Defects in mitochondrial metabolism and cancer.</gtr:title><gtr:parentPublicationTitle>Cancer &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a17271fe07cec6a3ad6c5b9ee6640b43"><gtr:id>a17271fe07cec6a3ad6c5b9ee6640b43</gtr:id><gtr:otherNames>Gaude E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2049-3002</gtr:issn><gtr:outcomeId>5436aa00166502.19445032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>434EBB1F-D4DE-4E1D-80DB-FF214445CBD8</gtr:id><gtr:title>Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells.</gtr:title><gtr:parentPublicationTitle>Cancer &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2adafad2f9a3124ace63cc227abbc312"><gtr:id>2adafad2f9a3124ace63cc227abbc312</gtr:id><gtr:otherNames>Zheng L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2049-3002</gtr:issn><gtr:outcomeId>5436abbc26ba21.78181808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F5E99FF-952D-45C4-97F3-46132B59EC38</gtr:id><gtr:title>A roadmap for interpreting (13)C metabolite labeling patterns from cells.</gtr:title><gtr:parentPublicationTitle>Current opinion in biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/067e4eaa1a86ae8b7fc14ae9aabed987"><gtr:id>067e4eaa1a86ae8b7fc14ae9aabed987</gtr:id><gtr:otherNames>Buescher JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0958-1669</gtr:issn><gtr:outcomeId>55d2dfc65434d0.21586234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDB27E46-F403-4380-A555-9B3F6A9D587E</gtr:id><gtr:title>Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61de41cef5e0acf82cff59ae4b6ce3a3"><gtr:id>61de41cef5e0acf82cff59ae4b6ce3a3</gtr:id><gtr:otherNames>Allen MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>5436aa01bdf173.08517594</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F548DB6-87D7-470A-ACEF-50982655C2A5</gtr:id><gtr:title>Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5eb9958ad6a76e20b7e1d439ad902026"><gtr:id>5eb9958ad6a76e20b7e1d439ad902026</gtr:id><gtr:otherNames>Catanzaro D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>55ed94487ce6f3.51051405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B29D52C5-C47C-424F-97C1-8465AEBEE1E5</gtr:id><gtr:title>Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17e12f0bf7b2d588d26d64444d86df65"><gtr:id>17e12f0bf7b2d588d26d64444d86df65</gtr:id><gtr:otherNames>Zecchini V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>5436aa00ea5c52.52974037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>793223AE-2144-4B0C-B7FB-BDDDC8D46525</gtr:id><gtr:title>A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration.</gtr:title><gtr:parentPublicationTitle>Molecular systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2de4c0d76977e46505843f808e6c5494"><gtr:id>2de4c0d76977e46505843f808e6c5494</gtr:id><gtr:otherNames>Yizhak K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1744-4292</gtr:issn><gtr:outcomeId>5436a9ffd36863.73910450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>443DFB19-49F6-44A9-9BB0-6694BA6771D4</gtr:id><gtr:title>Fumarate induces redox-dependent senescence by modifying glutathione metabolism.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2adafad2f9a3124ace63cc227abbc312"><gtr:id>2adafad2f9a3124ace63cc227abbc312</gtr:id><gtr:otherNames>Zheng L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>55d2dfc6c68b33.15515585</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E229D48D-5127-4F6F-AAFA-7B503F385ED3</gtr:id><gtr:title>A three-dimensional engineered tumour for spatial snapshot analysis of cell metabolism and&amp;nbsp;phenotype in hypoxic gradients.</gtr:title><gtr:parentPublicationTitle>Nature materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aef7aab0b92ca9ae4fafd989ef0a3e6"><gtr:id>6aef7aab0b92ca9ae4fafd989ef0a3e6</gtr:id><gtr:otherNames>Rodenhizer D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1476-1122</gtr:issn><gtr:outcomeId>5655f3b1d8da44.76501713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFC6F994-6282-417A-858B-EB1974B4653C</gtr:id><gtr:title>Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a71a540bba39918bfdfd516c6f54f977"><gtr:id>a71a540bba39918bfdfd516c6f54f977</gtr:id><gtr:otherNames>Matheson NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>5617c2a7b6f093.62780690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BDF62A6-AF98-4782-8F65-6BB86D7D7427</gtr:id><gtr:title>Succinate is an inflammatory signal that induces IL-1? through HIF-1a.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af464df264b306d774d5d2bbdd196c4e"><gtr:id>af464df264b306d774d5d2bbdd196c4e</gtr:id><gtr:otherNames>Tannahill GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_23275_25_23535595</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6ABD3274-8718-46ED-A17F-4B8589288670</gtr:id><gtr:title>Metabolic reprograming of mononuclear phagocytes in progressive multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af464df264b306d774d5d2bbdd196c4e"><gtr:id>af464df264b306d774d5d2bbdd196c4e</gtr:id><gtr:otherNames>Tannahill GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>55d2dfc61eb446.49214915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60254EEC-E503-414C-9D09-A8DC4E4F153F</gtr:id><gtr:title>Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b194fb2b4c2aca6f8612ef5f9eb99990"><gtr:id>b194fb2b4c2aca6f8612ef5f9eb99990</gtr:id><gtr:otherNames>Chouchani ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>55d2dfc76757f2.87805541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF12AB57-124F-4D34-82A1-6036894B003A</gtr:id><gtr:title>Germline FH mutations presenting with pheochromocytoma.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a1f7a0b056ac1558a2bea8616ac2f14a"><gtr:id>a1f7a0b056ac1558a2bea8616ac2f14a</gtr:id><gtr:otherNames>Clark GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>5436aa0047ead9.88087920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2A7E0E4-427A-492E-896D-656ACFFD5776</gtr:id><gtr:title>Proteomics-based metabolic modeling reveals that fatty acid oxidation (FAO) controls endothelial cell (EC) permeability.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d55f43b8b40349e28ed23380a6aea664"><gtr:id>d55f43b8b40349e28ed23380a6aea664</gtr:id><gtr:otherNames>Patella F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn><gtr:outcomeId>55d2dfc6f3e753.47099981</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7809688F-1930-46EC-B641-2DD6305B343D</gtr:id><gtr:title>Dysregulated metabolism contributes to oncogenesis.</gtr:title><gtr:parentPublicationTitle>Seminars in cancer biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cc11890ba11c0bdc469074b9e210924"><gtr:id>5cc11890ba11c0bdc469074b9e210924</gtr:id><gtr:otherNames>Hirschey MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1044-579X</gtr:issn><gtr:outcomeId>561ccd78d18fa6.44950275</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64769788-D84E-40F9-AC59-9696FB0B1C65</gtr:id><gtr:title>High throughput synthetic lethality screen reveals a tumorigenic role of adenylate cyclase in fumarate hydratase-deficient cancer cells.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c340f5b9b59df6b4e65286cefdd9954"><gtr:id>6c340f5b9b59df6b4e65286cefdd9954</gtr:id><gtr:otherNames>Boettcher M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>5436aa0134acb8.66314695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4546316C-B3B6-46C9-A3E4-65DF926E6A3D</gtr:id><gtr:title>The metabolic alterations of cancer cells.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf39094ef632ebbb42066741ffd829ea"><gtr:id>cf39094ef632ebbb42066741ffd829ea</gtr:id><gtr:otherNames>Sciacovelli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>5436aa00b1a953.21332258</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C5574E9-F69C-45C6-A746-41889FBEA736</gtr:id><gtr:title>Editorial: The Metabolic Challenges of Immune Cells in Health and Disease.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b9f929dc02cb31bf9c190aa1d55dcfc"><gtr:id>7b9f929dc02cb31bf9c190aa1d55dcfc</gtr:id><gtr:otherNames>Frezza C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>55d2dfc5d794c8.46195578</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>080725EF-64D7-4FCE-B75D-EC7D904F62F4</gtr:id><gtr:title>From tumor prevention to therapy: empowering p53 to fight back.</gtr:title><gtr:parentPublicationTitle>Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b9f929dc02cb31bf9c190aa1d55dcfc"><gtr:id>7b9f929dc02cb31bf9c190aa1d55dcfc</gtr:id><gtr:otherNames>Frezza C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1368-7646</gtr:issn><gtr:outcomeId>pm_23275_25_23164556</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CEC3022-22FE-4AB7-B24E-F598F1E38C39</gtr:id><gtr:title>Designing a broad-spectrum integrative approach for cancer prevention and treatment.</gtr:title><gtr:parentPublicationTitle>Seminars in cancer biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7c8a963fb0f2d5b1754c4986046b6f5"><gtr:id>c7c8a963fb0f2d5b1754c4986046b6f5</gtr:id><gtr:otherNames>Block KI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1044-579X</gtr:issn><gtr:outcomeId>5655f3b20c4083.35946598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>470231E2-F18B-4DE2-8DC3-4BAB7A1D770C</gtr:id><gtr:title>The role of mitochondria in the oncogenic signal transduction.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b9f929dc02cb31bf9c190aa1d55dcfc"><gtr:id>7b9f929dc02cb31bf9c190aa1d55dcfc</gtr:id><gtr:otherNames>Frezza C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>5436aa01808f35.60921906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8506B214-D2C1-45FB-B424-EE44F8917037</gtr:id><gtr:title>A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration</gtr:title><gtr:parentPublicationTitle>Molecular Systems Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2de4c0d76977e46505843f808e6c5494"><gtr:id>2de4c0d76977e46505843f808e6c5494</gtr:id><gtr:otherNames>Yizhak K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1744-4292</gtr:issn><gtr:outcomeId>55d2dfc68e16f1.15575998</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_1101/3</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>